About Harmonix
Harmonix is a venture capital firm founded in 2020. It is primarily based out of La Quinta, United States. As of Apr 2023, Harmonix has invested in 35 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Series B round of SentiAR Overall, Harmonix portfolio has seen 2 unicorns, 1 IPO and 5 acquisitions including key companies like Loft Orbital, Tarana and Momentus Space. A lot of funds co-invest with Harmonix, with names like Vanedge Capital sharing a substantial percentage of its portfolio. Harmonix has team of 5 people including 2 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B & 1 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Harmonix's List of Top Investments
Harmonix has a portfolio of 35 companies, including 2 unicorns. Their most notable investmentis in SorceroTheir portfolio spans across United States, Canada, Germany and 1 more locations. They have invested in Life Sciences, High Tech, Enterprise Applications and 8 other sectors, across stages such as Series A, Series B and 1 more. Here is the list of top investments by Harmonix:
1. Loft Orbital
Provider of space mission launch services. It offers microsatellite launching services. It includes platform manufacturing and integration, standard interfaces installation, launch booking and integration, regulatory compliance and licensing, and insurance. It also provides commissioning and routine operations through its global ground station partners. Its satellite operation dashboard enables payload tasking and access to data in near-real-time.
Key facts about Loft Orbital
- Founded Year: 2016
- Location: San Francisco (United States)
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $330M
- Employee Count: 336 as on Mar 31, 2026
- Investors: Foundation Capital, Flucas Ventures and 41 Others
- Latest Funding Round: Series C, Jan 15, 2025, $*****
- Highlight: Editors' Pick
2. Bit.bio
Manufacturer of programmed human cells for research and drug discovery. This entity utilizes gene-targeting technology to express transcription factors that reprogram induced pluripotent stem cells into defined human cell types. These products include various nerve, immune, and muscle cell lines designed for use in laboratory assays, disease modeling, and therapeutic development. The technology enables the production of consistent cell models for applications such as CRISPR screening, electrophysiology, and immunocytochemistry.
Key facts about Bit.bio
- Founded Year: 2016
- Location: Cambridge (United Kingdom)
- Annual Revenue: £1M - £10M as on Dec 31, 2024
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $266M
- Employee Count: 163 as on Jun 30, 2026
- Investors: Foresite Capital, Verition Fund Management and 53 Others
- Latest Funding Round: Series C, Jan 09, 2026, $*****
- Highlight: Editors' Pick
3. Tarana
Non-line-of-sight wireless transport solutions. Its product line includes a wireless transport solution, tools for deployment, and a carrier-class element management system application, as well as interfaces for northbound integration with carrier NMS systems to configure, monitor, and manage AA2 nodes in the field. Its AA2 wireless transport solution facilitates a suite of carrier networking features, such as timing and synchronization, MEF and carrier Ethernet standards compliance, northbound integration, and more.
Key facts about Tarana
- Founded Year: 2009
- Location: Milpitas (United States)
- Valuation: $*****
- Stage: Series D
- Total Funding till date: $426M
- Employee Count: 520 as on Jun 30, 2026
- Investors: AT&T, Trinity Capital and 18 Others
- Latest Funding Round: Series D, Sep 13, 2023, $*****
- Highlight: Editors' Pick
4. xCures
Developer of an AI-assisted healthcare data platform. It extracts and structures clinical information from medical records gathered across multiple sources. The AI-ready output is available through the xCures Platform UI, standard REST API integrations, and via flexible export and sync options.
Key facts about xCures
- Founded Year: 2018
- Location: Oakland (United States)
- Stage: Series B
- Total Funding till date: $76M
- Employee Count: 67 as on Jun 30, 2026
- Investors: Boehringer Ingelheim Venture Fund, Innovius Capital and 11 Others
- Latest Funding Round: Series B, Jun 25, 2026, $*****
- Highlight: Editors' Pick
5. Bioz
Developer of AI search engine for scientific experimentation. This platform provides researchers with scientific experimentation data, insights, and recommendations for products, equipment, and assays that help in drug discovery and finding cures for diseases.
Key facts about Bioz
- Founded Year: 2013
- Location: Los Altos (United States)
- Stage: Series A
- Total Funding till date: $17.5M
- Employee Count: 54 as on Jun 30, 2026
- Investors: StartX, SV Latam Capital and 13 Others
- Latest Funding Round: Grant (prize money), Apr 15, 2020, $*****
- Highlight: Editors' Pick
Harmonix's Year-on-Year Investment Trends
Harmonix has invested in 35 companies over the last 5 years, with an average of 1 new investment annually in the last 5 years. Its most recent first time investment was in SentiAR.Harmonix's Investments by Stage
Harmonix has made 2 investments in Series A stage with an average round size of $11.3M, 1 investment in Series B stage with an average round size of $8.5M and 1 investment in Series C stage with an average round size of $30M.Stage of entry | No. of Investments |
|---|---|
Series A | 2 |
Series B | 1 |
Series C | 1 |
Note: We have considered here, only first round of investments
Harmonix's Investments by Sector
Harmonix has a diverse portfolio, with companies operating in the Enterprise Applications, HealthTech, Vertical SaaS, Big Data - Industry Applications and AR VR - Industry Applications. Notably, it has invested in 34 Tech companies, 32 Enterprise (B2B) companies, 14 Software companies and at least 10 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Enterprise Applications | 4 |
HealthTech | 4 |
Vertical SaaS | 3 |
Big Data - Industry Applications | 2 |
AR VR - Industry Applications | 1 |
Others | 2 |
Note: We have considered here, only first round of investments
Harmonix's Investments by Geography
Harmonix has made most investments in United States (4).Harmonix's recent investments
Harmonix has not made any investment in 2026 so far.Here are the most recent investments by Harmonix:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Apr 11, 2023 | United States | Series B | 2262 | [+4] | |
Sep 16, 2021 | United States | Series A | 1970 | [+5] | |
Sep 16, 2021 | United States | Series C | 5811 | [+4] | |
Jun 23, 2021 | United States | Series A | 7806 | [+2] |
Unicorns in Harmonix's Portfolio
Harmonix has 2 unicorns in its portfolio - Loft Orbital and Tarana. The most recent unicorn in their portfolio is Loft Orbital. It became a unicorn in 2025, 1 years before Harmonix first invested in it.Here is a list of unicorns in Harmonix's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
68 | Provider of space mission launch services | 2016 | San Francisco | Series C | uzjybme | ||
65 | Non-line-of-sight wireless transport solutions | 2009 | Milpitas | Series D | iffg{mi |
IPOs and Publicly Listed companies in Harmonix's Portfolio
1 of Harmonix's portfolio company became public - Momentus Space. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Aug 2020.Here are Harmonix's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Aug 14, 2020 | - | - | 1534 |
Acquired companies in Harmonix's Portfolio
5 companies from Harmonix's portfolio have been acquired. The most recent acquisition was ATLAS Space.Here are Harmonix's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jul 18, 2025 | - | - | 6892 | |
Apr 02, 2025 | - | - | 1753 | |
Nov 16, 2023 | - | - | 3068 | |
Feb 06, 2023 | - | - | 8444 | |
Oct 27, 2021 | - | - | 5727 |
Team profile of Harmonix
Harmonix has a team of 5 members including 2 Partners located in United States and Puerto Rico. Harmonix's team does not sit on the board of any company as of now.Co-investors of Harmonix
Over the past 5 years, 54 investors have co-invested in Harmonix's portfolio companies. This includes funds and angels.
- Invested before Harmonix: Plug and Play Tech Center, Leawood Venture Capital and 26 others have invested in rounds before Harmonix. There are 2 companies where Plug and Play Tech Center has invested before Harmonix and 1 company where Leawood Venture Capital has invested before Harmonix.
- Top Co-investors of Harmonix: 12 investors entered a company along with Harmonix. These include investors like Vanedge Capital (1 company).
- Invested after Harmonix: A total of 14 investors have invested in Harmonix's portfolio after their investments. Top Investors include Innovius Capital (1 company), Igrow Venture (1 company) and GKCC (1 company).
Recent News related to Harmonix
•
Harmonix Announces the Final Close of Harmonix Fund III on October 31st, 2024PR Newswire•Aug 29, 2024•Harmonix
•
•
•
SentiAR Announces Close of $8.5 million Series B FinancingAiThority•Apr 12, 2023•SentiAR, Genesis, MedVenture Partners, TechWald Holding and 4 others
•
SentiAR, startup with holographic technology for heart procedures, raises $8.5M in Series B fundingThe Business Journals•Apr 12, 2023•SentiAR, Genesis, MedVenture Partners, TechWald Holding and 4 others
•
Missouri-based augmented reality startup SentiAr raised USD 8.5 million in Series B fundingVcbay News•Apr 12, 2023•SentiAR, MedVenture Partners, TechWald Holding, VCapital and 3 others
•
SentiAR Announces Close of $8.5 million Series B FinancingMedical Device News•Apr 11, 2023•SentiAR, Genesis, MedVenture Partners, TechWald Holding and 3 others
•
SentiAR Closes $8.5M Series B FinancingFinSMEs•Apr 11, 2023•SentiAR, MedVenture Partners, TechWald Holding, VCapital and 3 others
•
Digital surgery platform Caresyntax adds $30M to its Series CVator•Sep 17, 2021•Caresyntax, BlackRock, ProAssurance, PFM Health Sciences and 13 others
•
Sorcero Closes $10 Million Series A To Scale Language Intelligence PlatformPRWeb•Sep 16, 2021•Sorcero, H/L Ventures, Harmonix, Rackhousesteaks and 7 others
